<- Go Home
Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Market Cap
$2.8M
Volume
112.6K
Cash and Equivalents
$7.0M
EBITDA
-$7.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$35.20
52 Week Low
$1.36
Dividend
N/A
Price / Book Value
0.31
Price / Earnings
-0.07
Price / Tangible Book Value
0.31
Enterprise Value
-$3.8M
Enterprise Value / EBITDA
0.58
Operating Income
-$7.3M
Return on Equity
208.60%
Return on Assets
-62.88
Cash and Short Term Investments
$7.0M
Debt
$417.5K
Equity
$6.7M
Revenue
N/A
Unlevered FCF
-$4.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium